CSIMarket


Delmar Pharmaceuticals, Inc.  (DMPI)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare


 

Delmar Pharmaceuticals, Inc.

DMPI's Financial Statements and Analysis



Delmar Pharmaceuticals, Inc. reported in IV. Quarter net earnings per share of $1.25 an increase by 0 % year on year from $0.00 and an improvement of 576.51 % from $0.19 realized in IV. Quarter (Jun 30 2018).


IV. Quarter
Earnings Per Share Revenues
$ 1.25 $  0 Mill
$+1.25     Unch.    



Delmar Pharmaceuticals's Revenue fell by 0 % in IV. Quarter (Jun 30 2019) year on year, to $0 million and declined by sequentially.


Delmar Pharmaceuticals is

More on DMPI's Income Statement



Delmar Pharmaceuticals's net income of $5 million in IV. Quarter increased from net earnings of $0 million achieved in IV. Quarter a year ago.

Sequentially net earnings fell by -39.54 % from net income of $8.30 million realized in previous quarter.

More on DMPI's Growth

In IV. Quarter company's net cash and cash equivalents decreased by $-2 million


Delmar Pharmaceuticals, Inc. does not pay out common stock dividend.

In trailing twelve-month period Delmar Pharmaceuticals, Inc. earned $ 0.89 cash per share, on a free-cash flow basis 66.67 % of net earning per share.

Book value grew by 1,639.19 % sequentially to $0.50 per share, 37.15% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ 0.43 per share from $ 0.02.

Company repurchased 39.95 million shares or 91.02 % in IV. Quarter.
Interest Coverage Ratio was 2684.98.

More on DMPI's Dividends

 Market Capitalization (Millions) 2
 Shares Outstanding (Millions) 4
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) -
 Net Income (TTM) (Millions $) 17
 Cash Flow (TTM) (Millions $) -2
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -




Delmar Pharmaceuticals, Inc. does not pay out common stock dividend.

In trailing twelve-month period Delmar Pharmaceuticals, Inc. earned $ 0.89 cash per share, on a free-cash flow basis 66.67 % of net earning per share.

Book value grew by 1,639.19 % sequentially to $0.50 per share, 37.15% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ 0.43 per share from $ 0.02.

Company repurchased 39.95 million shares or 91.02 % in IV. Quarter.
Interest Coverage Ratio was 2684.98.

More on DMPI's Balance Sheets

 Market Capitalization (Millions) 2
 Shares Outstanding (Millions) 4
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) -
 Net Income (TTM) (Millions $) 17
 Cash Flow (TTM) (Millions $) -2
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -


   



             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SMGI's Profile

Stock Price

SMGI's Financials

Business Description

Fundamentals

Charts & Quotes

SMGI's News

Suppliers

SMGI's Competitors

Customers & Markets

Economic Indicators

SMGI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071